Tumour necrosis factor-alpha inhibitors decrease mortality in COVID-19: a systematic review and meta-analysis.

Jánosi Á, Bódy B, Nagy R, Ocskay K, Kói T, Müller K, Túri I, Garami M, Hegyi P, Párniczky A

Open source

DOI
10.1186/s13054-025-05420-9
Published
2025 Jun 6
Container
Critical care (London, England)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s13054-025-05420-9,
  title = {Tumour necrosis factor-alpha inhibitors decrease mortality in COVID-19: a systematic review and meta-analysis.},
  author = {Jánosi Á and Bódy B and Nagy R and Ocskay K and Kói T and Müller K and Túri I and Garami M and Hegyi P and Párniczky A},
  year = {2025},
  journal = {Critical care (London, England)},
  doi = {10.1186/s13054-025-05420-9},
  url = {https://doi.org/10.1186/s13054-025-05420-9}
}

RIS

TY  - JOUR
TI  - Tumour necrosis factor-alpha inhibitors decrease mortality in COVID-19: a systematic review and meta-analysis.
AU  - Jánosi Á
AU  - Bódy B
AU  - Nagy R
AU  - Ocskay K
AU  - Kói T
AU  - Müller K
AU  - Túri I
AU  - Garami M
AU  - Hegyi P
AU  - Párniczky A
PY  - 2025
JO  - Critical care (London, England)
DO  - 10.1186/s13054-025-05420-9
UR  - https://doi.org/10.1186/s13054-025-05420-9
ER  - 

APA

Á, J., B, B., R, N., K, O., T, K., K, M., I, T., M, G., P, H., & A, P. (2025). Tumour necrosis factor-alpha inhibitors decrease mortality in COVID-19: a systematic review and meta-analysis.. Critical care (London, England). https://doi.org/10.1186/s13054-025-05420-9

Source records